| Dec'19 | Dec'18 | |||||
|---|---|---|---|---|---|---|
Operating expenses: | ||||||
Research and development | ||||||
41,658 | 25,486 | |||||
General and administrative | ||||||
15,781 | 8,410 | |||||
Total operating expenses | ||||||
57,439 | 33,896 | |||||
Loss from operations | ||||||
-57,439 | -33,896 | |||||
Other income (expense): | ||||||
Interest income | ||||||
1,814 | 547 | |||||
Other income (expense) | ||||||
-1,598 | -2,173 | |||||
Other income | ||||||
34 | 79 | |||||
Change in fair value of preferred stock warrant liability | ||||||
51 | 14 | |||||
Interest expense | ||||||
3,395 | 2,785 | |||||
Net loss and comprehensive loss | ||||||
-59,037 | -36,069 | |||||
Net loss per share, basic and diluted (USD per share) | ||||||
-3.55 | -7.97 | |||||
Weighted average common shares outstanding, basic and diluted (in shares) | ||||||
16,624 | 4,546 | |||||